Showing results (231-240 of 6,267) with videos related to
Sort By:
Pageof 627
Cancer Research Communications|February 27, 2026
Social risk burden among U.S. cancer survivors across adulthood: Evidence from the 2022-2023 BRFSSAmi E Sedani, Bijal A Balasubramanian, Stephanie B Wheeler, et al.Japanese Circulation Journal|July 1, 1983
Noninvasive evaluation of arterial occlusive diseaseS Doko, B C Penney, F A Anderson, et al.Diabetes|January 30, 2004
Uncoupling protein 2 and islet functionCatherine B Chan, Monique C Saleh, Vasilij Koshkin, et al.Drug Discovery Today|June 4, 2019
Unbiased data analytic strategies to improve biomarker discovery in precision medicineSaifur R Khan, Yousef Manialawy, Michael B Wheeler, et al.Drug Discovery Today|January 21, 2021
Integration of AI and traditional medicine in drug discoverySaifur R Khan, Dana Al Rijjal, Anthony Piro, et al.Genomics|May 1, 1995
Gene-centromere mapping of bovine DYA, DRB3, and PRL using secondary oocytes and first polar bodies: evidence for four-strand double crossovers between DYA and DRB3V L Jarrell, H A Lewin, Y Da, et al.Journal of Ethnicity in Substance Abuse|July 23, 2020
Polysubstance use among frequent marijuana users: an examination of John Henryism Active Coping, psychiatric symptoms, and family social support among African American incarcerated menParis B Wheeler, Danelle Stevens-Watkins, Jardin N Dogan, et al.Endocrinology|August 25, 2012
Serotonin (5-HT) activation of immortalized hypothalamic neuronal cells through the 5-HT1B serotonin receptorStephanie Tung, Alexandre B Hardy, Michael B Wheeler, et al.The New Zealand Medical Journal|October 23, 2025
CTPA and pulmonary embolism rates between Māori and European populations in Hauora a Toi Bay of Plenty, New ZealandThomas H E Clark, Catherine Song, Matthew B Wheeler, et al.Annals of Medicine|March 5, 2024
Knowledge, experiences, and perceptions of medications for opioid use disorder among Black KentuckiansParis B Wheeler, Brittany Miller-Roenigk, Jasmine Jester, et al.Pageof 627